Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis

被引:0
作者
Kluwe, J [1 ]
Lohse, AW [1 ]
机构
[1] Univ Hamburg, Med Klin 1, D-20246 Hamburg, Germany
来源
INTERNIST | 2005年 / 46卷 / 12期
关键词
nonalcoholic fatty liver disease; insuline resistance; steatohepatitis; steatosis;
D O I
10.1007/s00108-005-1513-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized as one of the most common causes of chronic liver damage in the western world. It is strongly associated with insulin resistance, obesity and other features of the metabolic syndrome. The entity NAFLD embraces a clinical spectrum from benign steatosis over steatohepatitis to hepatic cirrhosis with its complications liver failure and hepatocellular carcinoma. Treatment is currently based on prescriptive diet and physical exercise. A well-defined pharmacotherapy of NAFLD still remains to be established due to the lack of randomized, controlled trials. Yet, for several drugs such as Metformin and Thiazolidinediones smaller trials report promising results.
引用
收藏
页码:1324 / +
页数:6
相关论文
共 28 条
[1]  
Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711
[2]   Nonalcoholic fatty liver disease [J].
Adams, LA ;
Angulo, P ;
Lindor, KD .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) :899-905
[3]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[4]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[5]   A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis [J].
Basaranoglu, M ;
Acbay, O ;
Sonsuz, A .
JOURNAL OF HEPATOLOGY, 1999, 31 (02) :384-384
[6]   Molecular mediators of hepatic steatosis and liver injury [J].
Browning, JD ;
Horton, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :147-152
[7]   A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease [J].
Bugianesi, E ;
Gentilcore, E ;
Manini, R ;
Natale, S ;
Vanni, E ;
Villanova, N ;
David, E ;
Rizzetto, M ;
Marchesini, G .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (05) :1082-1090
[8]  
Caldwell SH, 2001, AM J GASTROENTEROL, V96, P519
[9]   Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis [J].
Contos, MJ ;
Cales, W ;
Sterling, RK ;
Luketic, VA ;
Shiffman, ML ;
Mills, AS ;
Fisher, RA ;
Ham, J ;
Sanyal, AJ .
LIVER TRANSPLANTATION, 2001, 7 (04) :363-373
[10]  
Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x